{
    "code": "52027288",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027288",
    "time": "2021-10-15 03:30:28",
    "許可證字號": "衛部藥輸字第027288號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/11\/17",
    "發證日期": "106\/11\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202728803",
    "中文品名": "愛滅炎膜衣錠2毫克",
    "英文品名": "Olumiant film-coated tablets 2mg",
    "適應症": "1.\t類風濕性關節炎：合併methotrexate 或其他傳統型疾病緩解型抗風濕藥物(DMARDs)，用於治療患有中度到重度活動性類風濕性關節炎且對至少一種疾病緩解型抗風濕藥物(DMARDs)無法產生適當治療反應或無法耐受之成人病人；在這些病人中，若病人無法耐受或不適合繼續投與methotrexate 或其他傳統型疾病緩解型抗風濕藥物(DMARDs) ，可給予Olumiant 單獨治療。\r\n2.\t異位性皮膚炎：治療適合接受全身性治療的中度至重度異位性皮膚炎之成人病人。\r\n3.\tCOVID-19：與remdesivir 併用，適用於成人須氧氣輔助治療的新型冠狀病毒疾病(COVID-19，嚴重特殊傳染性肺炎)住院病人。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "111\/11\/17",
    "主成分略述": "Baricitinib",
    "限制項目": "02輸　入 1D須執行風險管理計畫 5E已執行國內臨床試驗 5F免除銜接性試驗",
    "申請商名稱": "1411301100  台灣禮來股份有限公司",
    "申請商地址": "台北市復興北路３６５號１１樓",
    "主製造廠": [
        {
            "": "PUERTO RICO",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FES0102000  LILLY S.A.",
            "製造廠廠址": "AVDA DE LA INDUSTRIA 30 28108 ALCOBENDAS MADRID SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013002510",
            "成分名稱": "Baricitinib",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "2mg tablets 大-107-09-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027288&Seq=002&Type=10"
        },
        {
            "title": "Olumiant 2mg 鋁箔-107-09-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027288&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Olumiant_給病人的資訊_Proposed Truth_EU SmPC_5Feb2021 v2 - Clean-110-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027288&Seq=013&Type=9"
        },
        {
            "title": "Olumiant_仿單_EU SmPC-Proposed Truth-27Sep2018_09Nov2017_20Sep2018_21Jul2020_21Jan2021-5Feb2021 v3- Clean-110-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027288&Seq=012&Type=9"
        },
        {
            "title": "Olumiant 2mg_鋁箔擬稿-108-01-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027288&Seq=004&Type=8"
        },
        {
            "title": "Olumiant 2mg 外盒-107-09-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027288&Seq=003&Type=8"
        },
        {
            "title": "0272880001-2mg Carton-106-12-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027288&Seq=002&Type=8"
        },
        {
            "title": "0272880002-2mg Blister-106-12-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027288&Seq=001&Type=8"
        }
    ]
}